What’s Going On With Iovance Biotherapeutics Stock?
Iovance Biotherapeutics announced Tuesday that the U.S. Food and Drug Administration (FDA) approved the company to begin analytical testing and manufacturing of AMTAGVI at its Philadelphia site. AMTAGVI received accelerated approval of its BLA on Feb. 16.
